Department of Orthopaedic Surgery, Centre Chirurgical Emile Gallé, University Hospital of Nancy, 49 Rue Hermite, 54000 Nancy, France.
Department of Orthopaedic Surgery, Centre Chirurgical Emile Gallé, University Hospital of Nancy, 49 Rue Hermite, 54000 Nancy, France.
Foot (Edinb). 2021 Mar;46:101748. doi: 10.1016/j.foot.2020.101748. Epub 2021 Jan 8.
At present, health facilities are forced to switch to outpatient care. While it lends itself well to this organizational arrangement, first ray surgery is broadly considered as painful by patients, who are often reluctant to this treatment. The evolution of post-operative pain in patients who underwent operations for first ray surgery from D0 to D15 were studied. Secondly, the duration of the oral analgesic treatment, the patient's satisfaction level, and searched for complications were assessed.
This is an observational, single-center and single-operator study. Between July and December 2019, forty patients who underwent first ray surgery (hallux valgus or rigidus) and eligible for outpatient treatment were included. The surgical technique of the hallux valgus treatment consisted of open surgery via double metatarsal and phalangeal osteotomy. The hallux rigidus surgery consisted of arthrodesis using an open dorsal plate. Home monitoring was carried out by a healthcare provider (e-HORUS). The protocol provided for pain management by means of a diffuser of Nefopam IV for a maximum of 5 days, combined with alleviating oral analgesics 1 and 2 and NSAIDs. The pain was evaluated on D0, D1, D3, D5, D8 and D15, using a numerical scale (NS) from 0 to 10. The degree of patient satisfaction was recorded at 1 month.
35 patients were followed. 5 patients were excluded due to incomplete data. The series included 26 women and 9 men, with an average age of 59.9 years. There were 30 hallux valgus and 5 hallux rigidus. The pain analyzed by the NS was 5.37 on D0, 3.34 on D1, 1.83 on D3, 1.43 on D5, 1.06 on D8 and 2.2 on D15. The average duration of Nefopam infusions was 3.89 days, and the average duration of oral analgesics was 17.7 days. The tolerance of the treatment was satisfactory in 79% of the cases. 69% of patients were very satisfied with the management of their pain. There were no scar complications or infections. No re-hospitalization was necessary. 3 algoneurodystrophies were identified. The existence of fibromyalgia or Parkinsonian syndrome was correlated with higher pain.
DISCUSSION-CONCLUSION: Pain management after outpatient first ray surgery using the injectable Nefopam protocol was satisfactory in the majority of cases, with a high degree of patient satisfaction. This protocol is routinely offered to our patients who must undergo first ray surgery.
目前,医疗机构被迫转向门诊治疗。虽然这种组织安排很合适,但第一跖骨手术被广泛认为是患者痛苦的,他们往往不愿意接受这种治疗。本研究旨在探讨第一跖骨手术后患者(踇外翻或僵硬)的术后疼痛演变,从第 0 天到第 15 天。其次,评估了口服镇痛治疗的持续时间、患者满意度水平以及是否存在并发症。
这是一项观察性、单中心和单操作医生研究。2019 年 7 月至 12 月,40 名接受第一跖骨手术(踇外翻或僵硬)且符合门诊治疗条件的患者入组。踇外翻手术的手术技术包括通过双跖骨和趾骨切开术进行开放式手术。僵硬手术包括使用开放式背侧钢板进行融合。家庭监测由医疗保健提供者(e-HORUS)进行。该方案规定使用 Nefopam IV 扩散器进行疼痛管理,最长不超过 5 天,并结合使用 1 级和 2 级口服镇痛药和 NSAIDs。使用数字量表(NS)从 0 到 10 评估第 0、1、3、5、8 和 15 天的疼痛。1 个月时记录患者满意度程度。
35 名患者得到了随访。由于数据不完整,有 5 名患者被排除。该系列包括 26 名女性和 9 名男性,平均年龄为 59.9 岁。有 30 例踇外翻和 5 例僵硬。NS 分析的疼痛分别为第 0 天 5.37、第 1 天 3.34、第 3 天 1.83、第 5 天 1.43、第 8 天 1.06 和第 15 天 2.2。Nefopam 输注的平均持续时间为 3.89 天,口服镇痛药的平均持续时间为 17.7 天。79%的病例治疗耐受性良好。69%的患者对疼痛管理非常满意。无疤痕并发症或感染。无需再次住院。发现 3 例神经痛性营养不良。纤维肌痛或帕金森综合征的存在与更高的疼痛相关。
讨论-结论:使用注射用 Nefopam 方案对门诊第一跖骨手术后的疼痛管理在大多数情况下是令人满意的,患者满意度很高。该方案常规提供给我们必须进行第一跖骨手术的患者。